BioSpace News Archive

JW Therapeutics Presents Primary Clinical Response on Carteyva® (relmacabtagene autoleucel injection) in Adults with Relapsed/Refractory Follicular Lymphoma in China at the 63rd ASH Annual Meeting

JW Therapeutics presented the primary clinical response on Carteyva® in adults with relapsed/refractory follicular lymphoma in China at the 63rd American Society of Hematology Annual Meeting.

December 14, 2021
·
3 min read
Genetown

Novanta to Present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022

Novanta Inc. announced that Matthijs Glastra, Chairperson and Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference, which is being held in person, on Tuesday, January 11, 2022, in San Francisco, California.

December 14, 2021
·
1 min read
Deals

Genenta Announces Pricing of Upsized Initial Public Offering - Dec 15, 2021

Genenta Science S.p.A. announced the pricing of its upsized initial public offering of 2.4 million American Depositary Shares, or ADSs, each representing one ordinary share, at a public offering price of $11.50 per share.

December 14, 2021
·
2 min read
Deals

BeiGene Announces Closing of Its RMB22.2 Billion (US$3.5 Billion) Initial Public Offering on the STAR Market of the Shanghai Stock Exchange in China

BeiGene, Ltd. announced that it has completed its previously announced initial public offering on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

December 14, 2021
·
6 min read